- Filed
- Apr 30, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 101.59M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $3.32B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $3.32B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $65M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $150M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $83M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $68M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $4.64B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $4.63B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $381M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $426M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $5.15B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.17B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $312M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $310M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $9.94B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 97.7M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $67M |
| Capex | Q1 2025 · Mar 31, 2024 | $98M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $241M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.99 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.00 |
| Net Income | Q1 2025 · Mar 31, 2024 | $97M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $124M |
| Revenue | Q1 2025 · Mar 31, 2024 | $240M |